Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

SARCLISA® : (Isa-VRd) Kostengutsprache-
gesuchformular

Doç. Dr. Beril Aydın Anlatıyor: RSV Nedir? Beyfortus ile Korunma

Doç. Dr. Beril Aydın'dan RSV ve Beyfortus'u dinleyelim.

Doç. Dr. Tolga Çelik Anlatıyor: RSV Nedir? Beyfortus ile Korunma

Doç. Dr. Tolga Çelik'den RSV ve Beyfortus'u dinleyelim.

Over 70 Years of Leadership in Influenza Vaccines

Sanofi has been at the forefront of influenza vaccine development for over 70 years, delivering more than 5 billion doses across 100+ countries and immunizing over 250 million people annually. With a robust global network of production sites spanning Canada, France, Mexico, the United States, Australia, and China, Sanofi continues to invest in cutting-edge R&D across egg-based, recombinant, and mRNA platforms — ensuring the world gets the right shot against flu

Type 2 Inflammation Throughout Life – Live Symposium for HCPs | April 24, 2026

Educational Livestream for Healthcare Professionals April 24, 2026 17:00–18:30 CET.

The Evolving Landscape of Disease Modification in Atopic Dermatitis - Current Evidence and Future Directions

The Evolving Landscape of Disease Modification in Atopic Dermatitis - Current Evidence and Future Directions

The Evolving Landscape of Disease Modification in Atopic Dermatitis - Current Evidence and Future Directions

The Evolving Landscape of Disease Modification in Atopic Dermatitis - Current Evidence and Future Directions

The Evolving Landscape of Disease Modification in Atopic Dermatitis - Current Evidence and Future Directions

Type 2 Inflammation Throughout Life – Live Symposium for HCPs | April 24, 2026

Educational Livestream for Healthcare Professionals April 24, 2026 17:00–18:30 CET.

Tulehdus 2.0 – tyypin 2 tulehdus läpi elämän - Helsinki 24.-25.4.2026

Koulutus järjestetään Helsingissä 24.-25.4.2026